Loading clinical trials...
Loading clinical trials...
PHASE 2, Multi-center, Single Arm Investigation of HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions
Interventions
HSPPC-96
Temozolomide
+1 more
Locations
9
United States
University of California, San Francisco
San Francisco, California, United States
University of Miami
Miami, Florida, United States
Northwestern University
Chicago, Illinois, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
The Valley Hospital
Paramus, New Jersey, United States
Northern Westchester Hospital
Mount Kisco, New York, United States
Start Date
June 29, 2009
Primary Completion Date
June 3, 2014
Completion Date
June 3, 2014
Last Updated
March 24, 2021
NCT00602667
NCT00978458
NCT00683319
NCT07416188
NCT00897286
NCT06742593
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions